JPRN-UMIN000006129招募中2 期
A randomized phase II study of pemetrexed versus pemetrexed plus carboplatin in chemotherapy-naive elderly patients with IIIB/IV non-squamous non-small cell lung cancer. - A randomized phase II study of MTA versus MTA plus CBDCA in elderly patients with IIIB/IV non-squamous NSCLC.
Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University0 个研究点目标入组 60 人开始时间: 2011年8月8日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Squamous cell carcinoma 2)Radiation therapy to primary cancer 3)SVC syndrome 4)Severe drug allergy 5)Massive or uncontrollable pleural effusion 6)Massive ascites, or pericardial effusion 7)Recurrence of postoperative NSCLC patients 8)Active infectious diseases 9)Interstitial pneumonia recognized by chest X-ray 10)CNS metastases with symptoms 11)Active multiple cancers 12)Psychological disorders 13)Inappropriate patients for this study judged by the physicians
研究者
相似试验
进行中（未招募）
不适用
Randomized phase II study of pemetrexed versus pemetrexed and carboplatin as second line chemotherapy in advanced non-small-cell lung cancer (NSCLC). - NDPreviously treated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).MedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastaticEUCTR2006-004009-24-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA
进行中（未招募）
不适用
A randomized phase II trial of pemetrexed with or without PF-3512676 for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of one prior chemotherapy regimen for advanced diseaseTreatment of patients with locally advanced or metastatic non-small lung cancer (NSLC) after failure of one prior chemotherapy regimen for advanced diseaseMedDRA version: MedLevel: VTcClassification code 10061873EUCTR2006-001588-52-DEPfizer Pharma GmbH130
已完成
不适用
A randomised phase II study of pemetrexed compared to pemetrexed-carboplatin in pretreated patients with advanced non-small cell lung cancerLung cancerCancerISRCTN38269072VU University Medical Centre (The Netherlands)230
已完成
不适用
A randomized phase II trial of Pemetrexed or Pemetrexed plus Carboplatin followed by maintenance Pemetrexed therapy for elderly chemotherapy naive stage IIIB/IV or postoperative recurrence non-squamous non-small cell lung cancer patientsJPRN-UMIN000008928Yushima Lung Cancer Oncology Group(YLOG)100
进行中（未招募）
不适用
A Randomized Phase 2 Study of Pemetrexed in Combination with Cisplatin or Carboplatin in the First Line Therapy of Advanced NSCLCadvanced NSCLC of Stage IIIb or IV undergoing first line chemotherapyEUCTR2006-002818-35-DEilly Deutschland GmbH